home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
The Arsenal Files 6
/
The Arsenal Files 6 (Arsenal Computer).ISO
/
health
/
med9603.zip
/
M9630298.TXT
< prev
next >
Wrap
Text File
|
1996-02-27
|
2KB
|
37 lines
Document 0298
DOCN M9630298
TI Prevention of SIV infection in macaques by
(R)-9-(2-phosphonylmethoxypropyl)adenine [see comments]
DT 9603
AU Tsai CC; Follis KE; Sabo A; Beck TW; Grant RF; Bischofberger N;
Benveniste RE; Black R; University of Washington Regional Primate
Research Center,; Seattle 98195, USA.
SO Science. 1995 Nov 17;270(5239):1197-9. Unique Identifier : AIDSLINE
MED/96072971
CM Comment in: Science 1995 Nov 17;270(5239):1121-2
AB The efficacy of pre- and postexposure treatment with the antiviral
compound (R)-9-(2-phosphonylmethoxypropyl)adenine (PMPA) was tested
against simian immunodeficiency virus (SIV) in macaques as a model for
human immunodeficiency virus (HIV). PMPA was administered subcutaneously
once daily beginning either 48 hours before, 4 hours after, or 24 hours
after virus inoculation. Treatment continued for 4 weeks and the
virologic, immunologic, and clinical status of the macaques was
monitored for up to 56 weeks. PMPA prevented SIV infection in all
macaques without toxicity, whereas all control macaques became infected.
These results suggest a potential role for PMPA prophylaxis against
early HIV infection in cases of known exposure.
DE Adenine/*ANALOGS & DERIVATIVES/ADMINISTRATION & DOSAGE/ PHARMACOLOGY
Animal Antibodies, Viral/BLOOD Antiviral Agents/ADMINISTRATION &
DOSAGE/*THERAPEUTIC USE Base Sequence Cells, Cultured Human HIV
Infections/DRUG THERAPY/*PREVENTION & CONTROL Injections, Subcutaneous
Leukocytes, Mononuclear/VIROLOGY Lymph Nodes/VIROLOGY Macaca
fascicularis Molecular Sequence Data Organophosphorus
Compounds/ADMINISTRATION & DOSAGE/*PHARMACOLOGY Simian Acquired
Immunodeficiency Syndrome/DRUG THERAPY/ *PREVENTION & CONTROL Support,
U.S. Gov't, P.H.S. SIV/*DRUG EFFECTS/IMMUNOLOGY/ISOLATION & PURIF
JOURNAL ARTICLE
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).